Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Merit Medical Systems is trading at 17–18x earnings with solid fundamentals and a reasonable valuation, supporting a positive outlook despite moderate organic growth in Q1. The company maintained and slightly raised its full-year sales guidance, aided by recent acquisitions. New growth drivers such as the View Point Medical acquisition and the WRAPSODY product line are expected to boost revenue and expand margins.
- ▪Merit Medical Systems trades at 17–18x earnings with solid fundamentals and moderate leverage.
- ▪Q1 organic growth was modest, but full-year sales guidance was maintained and slightly increased.
- ▪The View Point Medical acquisition and WRAPSODY are key growth engines expected to drive future revenue and margin expansion.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897702-merit-medical-systems-creating-more-growth-engines"},"author":{"@type":"Person","name":"The Value…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
